Article
Mutations in Gene fusA1 as a Novel Mechanism of Aminoglycoside Resistance in Clinical Strains of Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy - 1 Feb 2018
Bolard Arnaud, Plésiat Patrick, Jeannot Katy
Abstract excerpt
Resistance of clinical strains of Pseudomonas aeruginosa to aminoglycosides can result from production of transferable aminoglycoside-modifying enzymes, of 16S rRNA methylases, and/or mutational derepression of intrinsic multidrug efflux pump MexXY(OprM). We report here the characterization of a new type of mutant that is 4- to 8-fold more resistant to 2-deoxystreptamine derivatives (e.g., gentamicin, amikacin,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
